Robert Berman is Special Projects & Med Ovrsght at Biohaven Pharmaceutical Holding Co Ltd. (BHVN). They have made 26 open-market trades across 1 company since 2017, most recently 2020-07-08.
CIK 0001704483
2 open-market purchases totalling $107K since 2017, against 24 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BHVN | 3,119 | $34K |
Shares reported on the most recent Form 4, priced at the 2020-07-10 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BHVN | SELL | 2020-07-08 | 2020-07-10 | $75.25 | $8.8M | -2.2% | -16.8% | +3.6% |
| BHVN | SELL | 2020-06-23 | 2020-06-25 | $75.05 | $645K | +9.4% | -2.2% | -11.1% |
| BHVN | SELL | 2020-06-18 | 2020-06-22 | $75.26 | $9.3M | -5.0% | -2.6% | -20.4% |
| BHVN | SELL | 2019-12-30 | 2019-12-31 | $53.21 | $6.6M | -5.5% | -11.8% | -39.4% |
| BHVN | SELL | 2019-12-30 | 2019-12-31 | $53.21 | $13.3M | -5.5% | -11.8% | -39.4% |
| BHVN | BUY | 2019-06-27 | 2019-06-28 | $42.30 | $106K | -2.6% | +1.7% | -2.8% |
| BHVN | SELL | 2018-06-12 | 2018-06-12 | $37.07 | $97K | +8.1% | +11.5% | -4.2% |
| BHVN | SELL | 2018-06-11 | 2018-06-20 | $36.23 | $2.6M | -0.9% | -11.4% | -11.3% |
| BHVN | SELL | 2018-06-11 | 2018-06-12 | $36.16 | $501K | +8.1% | +11.5% | -4.2% |
| BHVN | SELL | 2018-06-08 | 2018-06-12 | $36.01 | $303K | +8.1% | +11.5% | -4.2% |
| BHVN | SELL | 2018-06-08 | 2018-06-12 | $36.33 | $3.8M | +8.1% | +11.5% | -4.2% |
| BHVN | SELL | 2018-06-05 | 2018-06-07 | $36.01 | $1.8M | +23.1% | +22.4% | +7.9% |
| BHVN | SELL | 2018-05-10 | 2018-05-14 | $26.80 | $1.8M | +21.0% | +35.2% | +17.4% |
| BHVN | SELL | 2018-04-10 | 2018-04-12 | $24.66 | $1.7M | -3.7% | +4.5% | +48.8% |
| BHVN | SELL | 2018-03-12 | 2018-03-14 | $30.11 | $2.1M | -20.1% | -7.3% | +30.6% |
| BHVN | SELL | 2018-02-12 | 2018-02-14 | $30.42 | $2.1M | +14.3% | -9.3% | -0.8% |
| BHVN | SELL | 2018-01-10 | 2018-01-12 | $27.25 | $724K | +24.0% | +17.3% | +5.3% |
| BHVN | SELL | 2018-01-10 | 2018-01-12 | $27.52 | $963K | +24.0% | +17.3% | +5.3% |
| BHVN | SELL | 2017-12-19 | 2017-12-20 | $24.10 | $241K | +6.1% | +16.6% | +7.7% |
| BHVN | SELL | 2017-12-11 | 2017-12-14 | $21.28 | $532K | +20.5% | +18.8% | +27.5% |
| BHVN | SELL | 2017-11-14 | 2017-11-14 | $24.42 | $802K | +5.9% | -10.5% | +24.7% |
| BHVN | SELL | 2017-11-13 | 2017-11-14 | $25.60 | $1.2M | +5.9% | -10.5% | +24.7% |
| BHVN | SELL | 2017-11-10 | 2017-11-14 | $26.31 | $1.4M | +5.9% | -10.5% | +24.7% |
| BHVN | SELL | 2017-11-09 | 2017-11-14 | $26.21 | $481K | +5.9% | -10.5% | +24.7% |
| BHVN | SELL | 2017-11-09 | 2017-11-14 | $25.76 | $4.1M | +5.9% | -10.5% | +24.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.